Table 4.

Hospitalizations by diagnosis groups versus comparison cohort

Number of hospitalizations (%)Number of admissionsaLength of stay (days)a
N01234≥5RRc95% CIPRRc95% CIP
Comparison (ref)7,21965.815.08.85.02.52.911
 Leukemias27353.815.412.56.24.08.11.841.652.05<0.0011.581.281.95<0.001
 Lymphomas26350.217.511.08.45.37.61.831.652.04<0.0011.351.171.55<0.001
 CNS/intracranial/intraspinal23043.020.013.08.34.411.31.711.531.92<0.0011.611.361.91<0.001
 Neuroblastoma6347.614.314.37.94.811.12.211.842.66<0.0011.301.041.640.02
 Renal tumors7664.519.77.94.01.32.60.610.410.900.011.100.85–1.430.45
 Malignant bone tumors6342.917.515.93.26.414.32.552.143.02<0.0011.401.071.840.02
 Sarcomas9751.621.79.36.23.18.31.821.542.16<0.0011.261.011.580.04
 Germ cell12554.423.29.63.24.05.61.150.93–1.420.201.261.001.600.05
 Epithelial25447.621.712.67.92.87.51.251.101.41<0.0011.110.95–1.290.20
 Otherb5552.716.49.15.55.510.92.191.792.68<0.0011.030.78–1.360.85

NOTE: Bold values indicate statistical significance at P < 0.05.

  • aAdjusted for sex as relevant, birth year, and diagnosis year. All estimates exclude hospitalizations for pregnancy and delivery.

  • bOther includes retinoblastoma/hepatic tumors/other unspecified tumors.

  • cRate ratios.